Mayumi Yamato Selected Research

Mayumi Yamato Research Topics

Disease

7	Body Weight (Weight, Body) 09/2020 - 07/2011
3	Neoplasms (Cancer) 04/2019 - 09/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2009 - 12/2003
2	Cognitive Dysfunction 01/2020 - 03/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017 - 08/2007
2	Inflammation (Inflammations) 01/2016 - 07/2014
2	Parkinson Disease (Parkinson's Disease) 06/2013 - 05/2008
2	Obesity 01/2012 - 08/2007
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2011 - 10/2009
2	Brain Ischemia (Cerebral Ischemia) 07/2011 - 12/2003
2	Ischemia 07/2011 - 10/2009
2	Myocardial Infarction 01/2009 - 03/2008
1	Fibrosis (Cirrhosis) 09/2020
1	Chronic Renal Insufficiency 09/2020
1	Dementia (Dementias) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Frailty 01/2019
1	Albuminuria 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Glycosuria 01/2019
1	Retinal Degeneration 10/2017
1	Diabetes Complications 03/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Epilepsy (Aura) 11/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Brain Diseases (Brain Disorder) 01/2015
1	Uremia 03/2014
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2014
1	Neuroblastoma 06/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2013
1	Scurvy (Scorbutus) 12/2012
1	Insulin Resistance 01/2012
1	Stomach Ulcer (Gastric Ulcer) 11/2011
1	Ulcer 11/2011
1	Rheumatoid Arthritis 11/2011
1	Experimental Arthritis 11/2011
1	Amyloid Plaque 05/2011
1	Alzheimer Disease (Alzheimer's Disease) 05/2011
1	Reperfusion Injury 09/2009
1	Infarction (Infarctions) 01/2009
1	Pathologic Processes 05/2008

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 11/2015 - 04/2006
5	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2011 - 12/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2012
3	LipidsIBA 10/2017 - 01/2012
3	Free RadicalsIBA 01/2015 - 09/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2020 - 01/2019
2	8-Hydroxy-2'-DeoxyguanosineIBA 09/2020 - 03/2016
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 09/2011
2	nitroxylIBA 11/2015 - 05/2011
2	Dopamine (Intropin)FDA LinkGeneric 06/2013 - 05/2008
2	Thiobarbituric Acid Reactive SubstancesIBA 05/2013 - 01/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2012 - 08/2007
1	CreatinineIBA 09/2020
1	Adenine FDA LinkGeneric 09/2020
1	Interleukin-6 (Interleukin 6)IBA 09/2020
1	Fatty Acid-Binding ProteinsIBA 09/2020
1	ipragliflozinIBA 09/2020
1	LinagliptinIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019
1	IronIBA 04/2019
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 04/2019
1	Annexin A5IBA 04/2019
1	Etoposide (VP 16)FDA LinkGeneric 04/2019
1	CanagliflozinIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Sodium-Glucose Transport ProteinsIBA 01/2019
1	Pioglitazone (Actos)FDA Link 07/2017
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 03/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2016
1	2,2,6- trimethyl- 4- (4- nitrobenzo(1,2,5)oxadiazol- 7- ylamino)- 6- pentylpiperidine- 1- oxylIBA 01/2016
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2016
1	Pentylenetetrazole (Metrazol)IBA 11/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2015
1	Superoxides (Superoxide)IBA 01/2015
1	Minocycline (Cyclops)FDA LinkGeneric 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	tempolIBA 07/2014
1	Thymidine Monophosphate (TMP)IBA 03/2014
1	Pentobarbital (Nembutal)FDA Link 01/2014
1	Messenger RNA (mRNA)IBA 06/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2012
1	Insulin (Novolin)FDA Link 01/2012
1	CholesterolIBA 01/2012
1	Bile Acids and Salts (Bile Acids)IBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Analgesics (Analgesic Drugs)IBA 11/2011
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2011
1	Lipid PeroxidesIBA 09/2011
1	Nifedipine (Adalat)FDA LinkGeneric 07/2011
1	LigandsIBA 05/2011
1	Amyloid (Amyloid Fibrils)IBA 05/2011
1	hydroxide ionIBA 05/2008
1	TEMPOL-HIBA 05/2008

Therapy/Procedure

2	Therapeutics 11/2015 - 04/2006
1	Intraperitoneal Injections 04/2019
1	Activities of Daily Living (ADL) 01/2019
1	Vagus Nerve Stimulation 03/2008